The COVID‐19 ibuprofen controversy: A systematic review of NSAIDs in adult acute lower respiratory tract infections
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The COVID‐19 ibuprofen controversy: A systematic review of NSAIDs in adult acute lower respiratory tract infections
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-08-18
DOI
10.1111/bcp.14514
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Covid-19: European drugs agency to review safety of ibuprofen
- (2020) Michael Day BMJ-British Medical Journal
- Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists
- (2020) Michael Day BMJ-British Medical Journal
- Risks Related to the Use of Non-Steroidal Anti-Inflammatory Drugs in Community-Acquired Pneumonia in Adult and Pediatric Patients
- (2019) Guillaume Voiriot et al. Journal of Clinical Medicine
- Nonsteroidal Antiinflammatory Drug Use and Clinical Outcomes of Community-acquired Pneumonia
- (2018) Damien Basille et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Eicosanoids, prostacyclin and cyclooxygenase in the cardiovascular system
- (2018) Jane A Mitchell et al. BRITISH JOURNAL OF PHARMACOLOGY
- Risk of stroke associated with use of nonsteroidal anti-inflammatory drugs during acute respiratory infection episode
- (2018) Yao-Chun Wen et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Risques associés à la prise d’anti-inflammatoires non stéroïdiens au cours de la pneumonie
- (2018) G. Voiriot et al. REVUE DES MALADIES RESPIRATOIRES
- Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Gregory A Roth et al. LANCET
- Acute Respiratory Infection and Use of Nonsteroidal Anti-Inflammatory Drugs on Risk of Acute Myocardial Infarction: A Nationwide Case-Crossover Study
- (2017) Yao-Chun Wen et al. JOURNAL OF INFECTIOUS DISEASES
- Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2017) Mohsen Naghavi et al. LANCET
- The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
- (2017) Simon D Harding et al. NUCLEIC ACIDS RESEARCH
- Prehospital NSAIDs use prolong hospitalization in patients with pleuro-pulmonary infection
- (2017) Ourania S. Kotsiou et al. RESPIRATORY MEDICINE
- Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data
- (2017) Michèle Bally et al. BMJ-British Medical Journal
- Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data
- (2017) Michèle Bally et al. BMJ-British Medical Journal
- Risk factors for local complications in children with community-acquired pneumonia
- (2016) Katarzyna Krenke et al. Clinical Respiratory Journal
- Nonsteroidal Anti-Inflammatory Drug and Aspirin Use, and Mortality among Critically Ill Pandemic H1N1 Influenza Patients: an Exploratory Analysis
- (2016) Holly Epperly et al. JAPANESE JOURNAL OF INFECTIOUS DISEASES
- Nonsteroidal Anti-Inflammatory Drug without Antibiotics for Acute Viral Infection Increases the Empyema Risk in Children: A Matched Case-Control Study
- (2016) Muriel Le Bourgeois et al. JOURNAL OF PEDIATRICS
- Non-steroidal Anti-inflammatory Drugs may Worsen the Course of Community-Acquired Pneumonia: A Cohort Study
- (2016) Damien Basille et al. LUNG
- Resolution of inflammation: a new therapeutic frontier
- (2016) James N. Fullerton et al. NATURE REVIEWS DRUG DISCOVERY
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- Possible Immunosuppressive Effects of Drug Exposure and Environmental and Nutritional Effects on Infection and Vaccination
- (2015) H. P. Huemer MEDIATORS OF INFLAMMATION
- Risks of nonsteroidal antiinflammatory drugs in undiagnosed intensive care unit pneumococcal pneumonia: Younger and more severely affected patients
- (2014) Jonathan Messika et al. JOURNAL OF CRITICAL CARE
- Risk factors for the development of pleural empyema in children
- (2014) Mohamed A. Elemraid et al. PEDIATRIC PULMONOLOGY
- Differential COX-2 induction by viral and bacterial PAMPs: Consequences for cytokine and interferon responses and implications for anti-viral COX-2 directed therapies
- (2013) Nicholas S. Kirkby et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Effectiveness of anti-inflammatory treatment versus antibiotic therapy and placebo for patients with non-complicated acute bronchitis with purulent sputum. The BAAP Study protocol
- (2011) Carl Llor et al. BMC Pulmonary Medicine
- Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies
- (2011) Patricia McGettigan et al. PLOS MEDICINE
- Prevalence and risk factors of suppurative complications in children with pneumonia
- (2010) Patrice François et al. ACTA PAEDIATRICA
- Nonsteroidal Antiinflammatory Drugs May Affect the Presentation and Course of Community-Acquired Pneumonia
- (2010) Guillaume Voiriot et al. CHEST
- Salicylates and Pandemic Influenza Mortality, 1918–1919 Pharmacology, Pathology, and Historic Evidence
- (2009) Karen M. Starko CLINICAL INFECTIOUS DISEASES
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started